There is currently a lack of therapeutic solutions for metastatic cancers. During the last two American Society of Clinical Oncology (ASCO) congresses in 2014 and 2015, immunotherapy was presented as a real hope of stabilization and even remission, for some patients. “Strategies using the immune system against the tumor are considered huge scientific breakthroughs,” noted the prestigious industry journal, Science (December 2013). “It’s not about targeting the tumor only, anymore, but to arm the immune system.”
Today, traditional approaches such as surgery, chemotherapy, radiotherapy and targeted therapies treat between 50% and 60% of cancers. But the issue is very different, depending on whether the cancer is localized or metastatic.
Treatments based on immune defenses represent a new weapon in the fight against cancer, most especially, advanced cancers.
OSE Immunotherapeutics Siège social
22, boulevard Benoni Goullin
Tel. :+33 (0)2 28 29 10 10 firstname.lastname@example.org
En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour réaliser des statistiques anonymes de visites. Vous pouvez vous y opposer en les désactivant. Pour cela, vous devez cliquer sur "NON".